Usted buscó: doxycycline (Inglés - Maltés)

interactions affecting doxycycline:
interazzjonijiet li jaffettwaw lil doxycycline:

the active substance is doxycycline.
is- sustanza attiva hi doxycycline.

antibiotics (e.g. clarithromycin, doxycycline)
antibijotiċi (eż. clarithromycin, doxycycline)

sub-therapeutic doxycycline concentrations may result.
jistgħu jirriżultaw konċentrazzjonijiet sotto- terapewtiċi ta ’ doxycycline.

100 mg of doxycycline base as hyclate excipients:
100 mg ta ’ bażi ta ’ doxycycline bħala hyclate sustanzi mhux attivi:

food can slightly modify oral bioavailability of doxycycline.
l- ikel jista ’ jimmodifika xi ftit il- bijodisponibilità orali ta ’ doxycycline.

oracea 40 mg modified release hard capsules doxycycline
oracea kapsuli iebsa ta ’ 40 mg li jerħu l- mediċina b' mod modifikat doxycycline

sunburn may occur in some people taking doxycycline.
peress li f’ ċertu persuni li qed jieħdu doxycycline jista ’ jkun hemm ħruq tax- xemx aktar sever.

international non-proprietary name (inn): doxycycline monohydrate
denominazzjoni komuni internazzjonali (dki): doxycycline monoidrat

each capsule contains 40 mg doxycycline (as monohydrate).
kull kapsula fiha 40 mg doxycycline (bħala monohydrate).

10 of doxycycline and the institution of specific antibiotic therapy.
din tista ’ tinkludi t- twaqqif ta ’ doxycycline u l- bidu ta ’ terapija antibijotika speċifika.

treat bacterial infections (e.g. clarithromycin, doxycycline)
jikkuraw l-infezzjonijiet batteriċi (eż. clarithromycin, doxycycline)

doxycycline is not eliminated to any great extent during haemodialysis.
doxycycline mhux eliminat bi kwantità kbira waqt emodijalisi.

ciprofloxacin, doxycycline, cefdinir: medicines to treat bacterial infections
ciprofloxacin, doxycycline, cefdinir: mediċini għall-kura ta’ infezzjonijiet batteriċi

doxycycline can be used by breast-feeding mothers for short term use only.
doxycycline jista ’ jintuża minn ommijiet li qed ireddgħu għall- perijodu ta ’ użu qasir biss.

concurrent use of cyclosporin has been reported to decrease the half-life of doxycycline.
l- użu fl- istess waqt ta ’ cyclosporin kien irrapportat li jnaqqas il- half- life ta ’ doxycycline.

doxycycline is contraindicated in children below age 12 (see section 4.3).
doxycycline huwa kontra- indikat fit- tfal taħt l- età ta ’ 12- il sena (ara sezzjoni 4. 3).

quinapril may reduce the absorption of doxycycline due to the high magnesium content in quinapril tablets.
quinapril jista ’ jnaqqas l- assorbiment ta ’ doxycycline minħabba l- kontenut ogħli ta ’ magnesium fil - pilloli quinapril.

oracea contains doxycycline in a formulation designed to yield plasma levels below the antimicrobial threshold.
oracea fih doxycycline f’ formulazzjoni ddisinjata biex tagħti livelli fil- plażma taħt il- limitu effettiv kontra l- mikrobi.

doxycycline has been shown to depress plasma prothrombin activity thereby potentiating the effect of anticoagulants of the dicoumarol type.
doxycycline intwera li jnaqqas l- attività ta ’ prothrombin fil- plażma u b’ hekk isaħħaħ l- effett ta ’ sustanzi kontra l- koagulazzjoni tad- demm tat- tip dicoumarol.